Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Drug Development Science Support (U01)

U.S. Food and Drug Administration·United States of America

Drug Development Science Support (U01)

Rolling / TBD close$500k – $5MGrants Notice
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The Food and Drug Administration (FDA) is accepting applications for a grant to support the development of new scientific knowledge, tools, standards, and approaches to evaluate products more effectively, predictably, and efficiently. The goal of this grant is to protect and promote the health of the American public. The grant is open to various types of organizations, including higher education institutions, nonprofits, for-profit organizations, and governments. The estimated project start date is September 1, 2020. • Eligible applicants include higher education institutions, nonprofits, for-profit organizations, and governments. • The grant will support the development of new scientific knowledge, tools, standards, and approaches to evaluate products. • The goal of the grant is to protect and promote the health of the American public. • The estimated project start date is September 1, 2020. • The grant is a cooperative agreement.

Attached files

The solicitation documents live at the source — open the bid source above to download them.

Contact

Shashi Malhotra(Grants Management Specialist)

[email protected]

(240) 402-7592

Key dates

Opened
5/25/2021
Closes
Rolling / TBD

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
541710
Solicitation №
FOR-FD-20-010

Budget estimate

$500,000 – $5,000,000

The budget for this grant is not specified, but based on the FDA's typical grant awards, it could range from $500,000 to $5 million. The actual budget will depend on the scope of the project, the number of awards, and the FDA's budget. The grant is a cooperative agreement, which means that the FDA will work closely with the grant recipient to achieve the project's goals.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 70%

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

Closes 11/5/2027Opened 11/15/2021

U.S. National Institutes of Health·United States of America

70% match

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

Closes 6/17/2027Opened 8/13/2026

U.S. Food and Drug Administration·United States of America

69% match

Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01)

Rolling / TBD closeOpened 11/24/2023

U.S. National Institutes of Health·United States of America

69% match

National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U01 Clinical Trial Optional)

Closes 10/25/2027Opened 1/15/2025

U.S. Food and Drug Administration·United States of America

69% match

Minor Use Minor Species Development of Drugs (R01)

Closes 1/29/2027Opened 5/29/2024

U.S. Food and Drug Administration·United States of America

68% match

Minor Use Minor Species Development of Drugs (R01)

Rolling / TBD closeOpened 11/30/2023

U.S. National Institutes of Health·United States of America

68% match

Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiological/Nuclear or Chemical Threats (U01 Clinical Trial Not Allowed)

Closes 10/9/2028Opened 4/9/2026

U.S. National Institutes of Health·United States of America

68% match

Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)

Closes 10/8/2027Opened 12/18/2024

U.S. Food and Drug Administration·United States of America

67% match

Identification of Drug-related and Formulation-Related Factors that Result in Alcohol Dose Dumping of Modified Release Oral Drug Products (U01) Clinical Trial Not Allowed

Rolling / TBD closeOpened 11/24/2023

U.S. National Institutes of Health·United States of America

67% match

National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional)

Closes 10/25/2027Opened 1/15/2025

U.S. Food and Drug Administration·United States of America

66% match

Novel approaches to support therapeutic development in ultra-rare cancers

Rolling / TBD closeOpened 8/4/2025

U.S. National Institutes of Health·United States of America

66% match

Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)

Closes 12/23/2027Opened 11/22/2024

U.S. Centers for Disease Control and Prevention - ERA·United States of America

66% match

NIOSH Mentored Research Scientist Development Award (K01)

Rolling / TBD closeOpened 9/1/2026

U.S. Food and Drug Administration·United States of America

66% match

Cooperative Agreement to Support Activities Related to Analgesics, Anesthetics, and Addiction (U01) Clinical Trials Allowed

Rolling / TBD closeOpened 8/14/2024

U.S. National Institutes of Health·United States of America

66% match

Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)

Closes 9/10/2027Opened 12/13/2024

U.S. National Institutes of Health·United States of America

65% match

Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)

Closes 9/7/2027Opened 3/8/2022

U.S. National Institutes of Health·United States of America

65% match

Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required)

Closes 5/7/2027Opened 4/24/2024

U.S. National Institutes of Health·United States of America

65% match

Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development

Closes 6/15/2027Opened 7/7/2026

U.S. National Institutes of Health·United States of America

65% match

Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)

Closes 3/10/2027Opened 9/18/2025

U.S. Food and Drug Administration·United States of America

65% match

Cooperative Agreement for Long Term Data Collection on Antimicrobial Use in Animals (U01) Clinical Trial Not Allowed

Rolling / TBD closeOpened 11/29/2023

U.S. National Institutes of Health·United States of America

65% match

Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed)

Closes 5/7/2027Opened 4/24/2024

U.S. National Institutes of Health·United States of America

65% match

First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required)

Closes 10/15/2027Opened 11/26/2024

U.S. Department Of Defense·Maryland

65% match

Generative Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S. interagency, academic and industry partners

Closes 10/18/2028Opened 9/23/2026

U.S. National Institutes of Health·United States of America

65% match

Technology Development Program

Closes 2/4/2028Opened 9/16/2026

U.S. National Institutes of Health·United States of America

65% match

Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)

Closes 1/7/2028Opened 3/25/2021